{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:17:21Z","timestamp":1791764241934,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Health Development Planning Commission of Zhejiang Province","award":["2017KY655"],"award-info":[{"award-number":["2017KY655"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biopha.2018.08.042","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T10:29:47Z","timestamp":1534933787000},"page":"849-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["EGFR aptamer-conjugated liposome-polycation-DNA complex for targeted delivery of SATB1 small interfering RNA to choriocarcinoma cells"],"prefix":"10.1016","volume":"107","author":[{"given":"Jinhua","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.08.042_bib0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2016.03.026","article-title":"Intraplacental choriocarcinoma: systematic review and management guidance","volume":"141","author":"Jiao","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2018.08.042_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13048-017-0334-3","article-title":"A gestational choriocarcinoma of the ovary diagnosed by DNA polymorphic analysis: a case report and systematic review of the literature","volume":"10","author":"Jia","year":"2017","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.biopha.2018.08.042_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2017.12.007","article-title":"Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?","volume":"148","author":"Braga","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2018.08.042_bib0020","series-title":"\"Cancer Chemotherapy\". Basic and Clinical Pharmacology","author":"Katzung","year":"2006"},{"key":"10.1016\/j.biopha.2018.08.042_bib0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/s12885-018-4512-5","article-title":"Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2018.08.042_bib0030","series-title":"Haines & Tailor Obstetrical and Gynecological Pathology","first-page":"771","article-title":"Germ cell tumors of the ovary","author":"Nogales","year":"2003"},{"key":"10.1016\/j.biopha.2018.08.042_bib0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1440-1827.2006.02016.x","article-title":"Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis","volume":"56","author":"Koo","year":"2006","journal-title":"Pathol. Int."},{"key":"10.1016\/j.biopha.2018.08.042_bib0040","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.gt.3301923","article-title":"Gene therapy progress and prospects: nonviral vectors","volume":"9","author":"Niidome","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2018.08.042_bib0045","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","article-title":"Gene therapy progress and prospects: non-viral gene therapy by systemic delivery","volume":"13","author":"Li","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2018.08.042_bib0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2007.08.007","article-title":"Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents","volume":"107","author":"Chen","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2018.08.042_bib0055","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2004-2458","article-title":"Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis","volume":"90","author":"Hamada","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2018.08.042_bib0060","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.biomaterials.2011.01.034","article-title":"The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes","volume":"32","author":"Gao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2018.08.042_bib0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biomaterials.2011.09.035","article-title":"EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma","volume":"33","author":"Gao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2018.08.042_bib0070","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.biomaterials.2009.11.112","article-title":"Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing","volume":"31","author":"Gao","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2018.08.042_bib0075","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.2174\/0929867322666151001121601","article-title":"Non-viral delivery systems for the application in p53 cancer gene therapy","volume":"35","author":"Wang","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2018.08.042_bib0080","series-title":"Bioinspired and Biomimetic Polymer Systems for Drug and Gene Delivery","first-page":"223","article-title":"Charge-reversal polymers for biodelivery","author":"Zhang","year":"2014"},{"key":"10.1016\/j.biopha.2018.08.042_bib0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semcancer.2012.06.009","article-title":"Genome organizing function of SATB1 in tumor progression","volume":"23","author":"Kohwi-Shigematsu","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2018.08.042_bib0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1600-0463.2010.02673.x","article-title":"Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features","volume":"118","author":"Cheng","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.biopha.2018.08.042_bib0095","first-page":"981","article-title":"SATB1 is an independent prognostic marker for gastric cancer in a Chinese population","volume":"24","author":"Lu","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2018.08.042_bib0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/17455057.4.4.329","article-title":"Is SATB1 a master regulator in breast cancer growth and metastasis?","volume":"4","author":"Zheng","year":"2008","journal-title":"Womens Health (Lond. Engl.)"},{"key":"10.1016\/j.biopha.2018.08.042_bib0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1091\/mbc.7.4.541","article-title":"Contrasting effects of the SATB1 core nuclear matrix attachment region and flanking sequences of the keratin 18 gene in transgenic mice","volume":"7","author":"Neznanov","year":"1996","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2018.08.042_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2867-13-8","article-title":"Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells","volume":"13","author":"Huang","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2018.08.042_bib0115","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2174\/1389557513666131119202717","article-title":"Antibody-targeted immunoliposomes for cancer treatment","volume":"13","author":"Gao","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2018.08.042_bib0120","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2217\/nnm.10.94","article-title":"Antibody engineering promotes nanomedicine for cancer treatment","volume":"5","author":"Gao","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.biopha.2018.08.042_bib0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2018.08.042_bib0130","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-04-2550","article-title":"Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells","volume":"64","author":"Farokhzad","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.08.042_bib0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/gyno.2000.5777","article-title":"Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor","volume":"77","author":"Tuncer","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2018.08.042_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0143-4004(97)90067-9","article-title":"Relative expression of epidermal growth factor receptor in placental cytotrophoblasts and choriocarcinoma cell lines","volume":"18","author":"Filla","year":"1997","journal-title":"Placenta"},{"key":"10.1016\/j.biopha.2018.08.042_bib0145","first-page":"1247","article-title":"Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells","volume":"15","author":"Yu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2018.08.042_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"Herbst","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218342392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218342392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:47:23Z","timestamp":1766026043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218342392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":30,"alternative-id":["S0753332218342392"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.042","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR aptamer-conjugated liposome-polycation-DNA complex for targeted delivery of SATB1 small interfering RNA to choriocarcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}